Resumo

NAVARRO-CASTILLO, Pablo. Handling decompensated cirrhosis. Acta méd. costarric [online]. 2008, vol.50, suppl.3, pp.77-79. ISSN 0001-6002.

All cirrhotic patients and detectable DNA HBV must take antiviral treatment. Treatment should start with lamivudine or adenofir dipivoxil. Alpha interferon in any presentation is contraindicated. Constant monitoring (every 3 moths) of DNA HBV levels of patients with lamiduvine must be carried aout to detect drug resistance. When DNA HBV reappers or increases itself in 1 log_10, it is believed that resistance against lamiduvine is being developed. In case of resistance, treatment with adenofir dipivoxil should be srted (every 3 months) of their renal function.

Palavras-chave : cirrhosis; treatment; lamivudina; adefovir.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )